Trial Profile
Phase I study of DE-105 in patients with severe persistent corneal epithelial defects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Apr 2015
Price :
$35
*
At a glance
- Drugs RU 105 (Primary)
- Indications Corneal disorders
- Focus Adverse reactions; Therapeutic Use
- 29 Apr 2015 New trial record